Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Bravaccini

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|January 8, 2018
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines  for the adjuvant treatment of early breast cancer?Sara Bravaccini, Andrea Rocca, Giuseppe Bronte
European Journal of Cancer (Oxford, England : 1990)|November 15, 2022
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer"Sara Bravaccini, Maurizio Puccetti, Roberta Maltoni
Breast Care (Basel, Switzerland)|October 30, 2023
Biomarkers: Which Ones Do We Really Need Today?Angelo Paradiso, Sara Bravaccini, Paolo Pronzato
Methods in Molecular Biology (Clifton, N.J.)|March 2, 2021
Urinary Biomarkers in Tumors: An OverviewIlaria Cimmino, Sara Bravaccini, Claudio Cerchione
International Journal of Molecular Sciences|July 2, 2021
TMB in NSCLC: A Broken Dream?Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
Breast Cancer Research and Treatment|June 13, 2023
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the countrySara Bravaccini, Massimiliano Mazza, Roberta Maltoni
Seminars in Cancer Biology|April 20, 2019
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancerSamanta Salvi, Massimiliano Bonafè, Sara Bravaccini
Breast Cancer Research and Treatment|February 27, 2018
What to look for in cell-free DNA from breast cancer patientsGiuseppe Bronte, Sara Ravaioli, Sara Bravaccini
Seminars in Cancer Biology|November 1, 2019
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancerFrancesco Fabbri, Samanta Salvi, Sara Bravaccini
Frontiers in Medicine|March 18, 2022
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy ResistanceMichele Zanoni, Sara Bravaccini, Francesco Fabbri, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|January 8, 2018
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines  for the adjuvant treatment of early breast cancer?Sara Bravaccini, Andrea Rocca, Giuseppe Bronte
European Journal of Cancer (Oxford, England : 1990)|November 15, 2022
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer"Sara Bravaccini, Maurizio Puccetti, Roberta Maltoni
Breast Care (Basel, Switzerland)|October 30, 2023
Biomarkers: Which Ones Do We Really Need Today?Angelo Paradiso, Sara Bravaccini, Paolo Pronzato
Methods in Molecular Biology (Clifton, N.J.)|March 2, 2021
Urinary Biomarkers in Tumors: An OverviewIlaria Cimmino, Sara Bravaccini, Claudio Cerchione
International Journal of Molecular Sciences|July 2, 2021
TMB in NSCLC: A Broken Dream?Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
Breast Cancer Research and Treatment|June 13, 2023
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the countrySara Bravaccini, Massimiliano Mazza, Roberta Maltoni
Seminars in Cancer Biology|April 20, 2019
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancerSamanta Salvi, Massimiliano Bonafè, Sara Bravaccini
Breast Cancer Research and Treatment|February 27, 2018
What to look for in cell-free DNA from breast cancer patientsGiuseppe Bronte, Sara Ravaioli, Sara Bravaccini
Seminars in Cancer Biology|November 1, 2019
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancerFrancesco Fabbri, Samanta Salvi, Sara Bravaccini
Frontiers in Medicine|March 18, 2022
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy ResistanceMichele Zanoni, Sara Bravaccini, Francesco Fabbri, et al.
Pageof 15